A group of America's most powerful CEOs said companies should no longer merely focus on maximizing shareholder wealth. A business professor explains why it's not a big deal.
Academic rigor, journalistic flair
Articles on Pfizer
Displaying all articles
Because we're still not sure exactly what causes dementia, finding a treatment is difficult.
Pharmaceutical giant Pfizer has engaged in a series of paper transactions to create a A$936 million loss in Australia – effectively a billion-dollar exercise in avoiding tax.
The high cost of cancer drugs in South Africa has come under the spotlight with an investigation by the Competition Commission in the country.
Obama calls them insidious and others have described inversions as unpatriotic, but what they really do is show just how much of a mess the corporate tax code is.
The furore over US pharmaceuticals giant Pfizer’s attempted takeover of UK rival AstraZeneca continues. AstraZeneca has now rejected Pfizer’s “final” offer, as it says the proposed deal “undervalues the…
Pfizer is like Woody Allen’s famous shark. It has to keep moving or it will die. And the drug company seems unable to keep moving by any means other than acquisitions. Its all-time best-selling drug, Lipitor…
Those for whom Viagra is indispensable might be a little surprised that the ubiquitous blue, diamond-shaped pill was a chance discovery by a group of research pharmaceutical chemists at Pfizer’s research…
First it was the Pharmacy Guild’s deal with Blackmores that raised ethical concerns. Now it’s the Guild and Pfizer. Both deals involve undisclosed payments from drug companies to Guild subsidiaries to…
Top contributors
-
Professor of Business, University of Michigan
-
Ken Harvey is a Friend of The Conversation.
Associate Professor, School of Public Health and Preventive Medicine, Monash University
-
Emeritus Professor of Accounting, University of Essex, University of Essex
-
Lecturer in Law, Ulster University
-
Assistant researcher, University of Sydney
-
Distinguished Professor of Management & Global Business, Rutgers University
-
Science Writer, Queensland Brain Institute, The University of Queensland
-
Associate Professor and Course Leader: Post Graduate Programmes in Clinical Pharmacy in the Department of Pharmacy, Sefako Makgatho Health Sciences University
-
Adjunct Associate Professor, School of Social and Political Sciences, University of Sydney
-
Director, Clem Jones Centre for Ageing Dementia Research, The University of Queensland
